Mar 10

Leukocyte-rich PRP for Knee Osteoarthritis: Current Concepts. 

Osteoarthritis is one of the most debilitating degenerative conditions affecting more than a third of the population of active individuals over the age of 65. Upon onset of clinical manifestations, osteoarthritis (OA) may become increasingly destructive regarding disease progression with respect to the microenvironment. Investigations into the leukocyte concentration in PRP formulations and its effect on the healing process in OA has created some controversy in evidence-based practice. It is well known that the inflammatory phase is integral to the...

Feb 22

New Biologics Guidelines for Low Back Pain

[section_tc][column_tc span='12'][text_tc trigger_pt='0' duration='1000' delay='0']The use of regenerative medicine has been expanding as its power to help heal patients has become increasingly apparent. However, the decision about what and who to treat with these therapeutic compounds can be tricky, especially given the variable and occasionally scarce data about certain applications. TOBI Alumni Faculty, Annu Navani has spearheaded a massive effort in collaboration with the American Society of Interventional Pain Physicians (ASIPP) to bring clarity to the use of biologic therapies...

Dec 5

Dr. Victor Ibrahim Memorial Scholarships to TOBI X 2019

The Orthobiologic Institute (TOBI) honors Dr. Victor Ibrahim's legacy with the Dr. Victor Ibrahim Memorial Orthobiologic Scholarship to provide registrations to TOBI X 2019 to Residents, Fellows, Military, or Physicians in underserved regions. Each scholarship provides registration to The Orthobiologic Institute (TOBI) 10th Annual PRP & Regenerative Medicine Symposium, Workshops and Cadaver Labs, June 6-8, 2019 at McCormick Place, Chicago, Illinois, USA. Please join us by sharing this opportunity with students, military, and physicians who will benefit from this education,...